Kadcyla, Keytruda, Imfinzi in Line for Label Expansion in August

July 20, 2020
The Ministry of Health, Labor and Welfare (MHLW) is expected to add new indications for several major drugs as early as August, including MSD’s I/O star Keytruda (pembrolizumab) for use in advanced esophageal cancer, with their approval plans reported to...read more